CD248 and neoplasm: E3K CAR T-cells showed specific killing activity against CD248-positive cells in three immunocompetent mouse models (BALB/c, FVB/N, and C57BL/6), effectively clearing target cells from the TME, resulting in increased tumor necrosis and growth inhibition [207].